Dataset Information


Atherogenic dyslipidaemia and cardiovascular events in patients with diabetes or pre-diabetes and stable coronary artery disease: a prospective, cohort study.



The aim of the study was to investigate the impacts of triglyceride (TG) and high-density lipoprotein cholesterol (HDL-C) dyslipidaemia on prognosis in coronary artery disease (CAD) patients with different glucose metabolism status.


An observational cohort study.


A total of 3057 patients with stable CAD were consecutively enrolled and divided into three groups according to different glucose metabolism status. Atherogenic dyslipidaemia (AD) was defined as TG ?1.7 mmol/L and HDL-C <1.0 mmol/L for men or <1.3 mmol/L for women. The patients were further classified into six subgroups by status of AD. All subjects were followed up for the cardiovascular events (CVEs).

Primary outcome measures

The primary endpoints were cardiovascular mortality, non-fatal myocardial infarction and non-fatal stroke.


During a median follow-up of 6.1 years, 308 (10.1%) CVEs occurred. No significant difference in the occurrence of CVEs was observed between normal glucose regulation (NGR) and pre-diabetes (pre-DM) groups (HR: 1.25, 95% CI 0.89 to 1.76) while DM group presented 1.45-fold higher risk of CVEs (HR: 1.45, 95% CI 1.02 to 2.05). When the participants were categorised according to combined status of two parameters, the cardiovascular risk was significantly elevated in pre-DM or DM plus AD group compared with the NGR plus non-AD group (HR: 1.76, 95% CI 1.10 to 2.80 and HR: 1.87, 95% CI 1.17 to 2.98).


The present study suggested that the presence of AD might affect the prognosis in patients with DM or pre-DM and stable CAD.

PROVIDER: S-EPMC7813370 | BioStudies |

REPOSITORIES: biostudies

Similar Datasets

| S-EPMC7011523 | BioStudies
| S-EPMC6791018 | BioStudies
| S-EPMC7520976 | BioStudies
| S-EPMC7118853 | BioStudies
| S-EPMC8283976 | BioStudies
| S-EPMC6553564 | BioStudies
| S-EPMC5529507 | BioStudies
| S-EPMC8748924 | BioStudies
| S-EPMC7469882 | BioStudies
| S-EPMC9240290 | BioStudies